DrugDashboards

Vancomycin

Vancomycin · VANCOMYCIN 1.25 g/250mL · Injection, Solution · Intravenous · Xellia Pharmaceuticals USA LLC

NDC 70594-0057-02 · 6 BAG in 1 CARTON / 250 mL in 1 BAG · NDA · View full market →

The short version

Just 2 companies supply this market — thin enough that a single exit would be felt immediately.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

One drug, every price

The same NDC has different prices depending on who is paying. Units differ between rungs — compare within a rung over time, not rung against rung, unless the units match.

ⓘ How this was built
Data sources
  • CMS NADAC (pharmacy acquisition, weekly)
  • CMS Part B ASP quarterly payment limits
  • CMS Maximum Fair Prices (IRA negotiated, NDC-level)
  • Medicare Part D Spending by Drug (data.cms.gov, name-matched)
  • VA FSS / Big4 federal contract prices (va.gov, twice monthly)
  • ACA Federal Upper Limits + weighted AMP (data.medicaid.gov, monthly)
  • California SB-17 WAC filings (list price, per package)
Method

Each rung is the newest figure for this NDC from one federal price system, shown with its own unit. Part D is matched by drug name because CMS publishes no NDCs there; it is gross spending, before confidential rebates.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

  • Medicare Part B pays (ASP+6%)$0.1420per billing unit (10 MG)HCPCS J3375 · Jul 1, 2026
  • Part D plans paid (avg)$0.0873per dosage unitgross, before rebates — matched by drug name · 2024

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Estimated fill cost

WAC per package, as filed
$114.00
Reported to Texas DSHS · 2026 annual filing · Hikma Pharmaceuticals USA Inc.

Manufacturer list price as filed — not what pharmacies actually pay after discounts.

Medicare Part B (ASP)

Payment limit per 10 MG
$0.142
HCPCS J3375 · Jul 1, 2026 quarter · typically ASP + 6%

Medicaid spend (2025)

$333,327
3,604 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill · avg $53.21 per prescription
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program

Regulatory

Application
NDA211962
TE code
—
Approval date
Feb 15, 2019
Patents / exclusivity
42 patents, 0 exclusivities
TypeNumber / codeExpires
patent10188697Nov 6, 2035
patent10039804Nov 6, 2035
patent10188697Nov 6, 2035
patent10188697Nov 6, 2035
patent10039804Nov 6, 2035
patent11517609Nov 6, 2035
patent11517609Nov 6, 2035
patent11517609Nov 6, 2035
patent11517609Nov 6, 2035
patent11517609Nov 6, 2035
patent11517609Nov 6, 2035
patent11517609Nov 6, 2035

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Vancomycin (Injection, Solution)

LabelerStrengthFirst seenLast seen
Hikma Pharmaceuticals USA Inc.VANCOMYCIN 1.5 g/300mLJul 15, 2026Sep 2, 2026
Hikma Pharmaceuticals USA Inc.VANCOMYCIN 2 g/400mLJul 15, 2026Sep 2, 2026
Hikma Pharmaceuticals USA Inc.VANCOMYCIN 1.25 g/250mLJul 15, 2026Sep 2, 2026
Hikma Pharmaceuticals USA Inc.VANCOMYCIN 500 mg/100mLJul 15, 2026Sep 2, 2026
Hikma Pharmaceuticals USA Inc.VANCOMYCIN 1.75 g/350mLJul 15, 2026Sep 2, 2026
Hikma Pharmaceuticals USA Inc.VANCOMYCIN 750 mg/150mLJul 15, 2026Sep 2, 2026
Hikma Pharmaceuticals USA Inc.VANCOMYCIN 1 g/200mLJul 15, 2026Sep 2, 2026
Xellia Pharmaceuticals USA LLCVANCOMYCIN 750 mg/150mLJul 15, 2026Sep 2, 2026
Xellia Pharmaceuticals USA LLCVANCOMYCIN 1 g/200mLJul 15, 2026Sep 2, 2026
Xellia Pharmaceuticals USA LLCVANCOMYCIN 1.25 g/250mLJul 15, 2026Sep 2, 2026
Xellia Pharmaceuticals USA LLCVANCOMYCIN 1.5 g/300mLJul 15, 2026Sep 2, 2026
Xellia Pharmaceuticals USA LLCVANCOMYCIN 1.75 g/350mLJul 15, 2026Sep 2, 2026
Xellia Pharmaceuticals USA LLCVANCOMYCIN 2 g/400mLJul 15, 2026Sep 2, 2026
Xellia Pharmaceuticals USA LLCVANCOMYCIN 500 mg/100mLJul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Vancomycin — NDC 70594-0057-02," retrieved September 3, 2026, https://drugdashboards.com/drug/70594005702.

Free to cite with attribution — see how the data is put together.